Risk Factors Associated with the Development of Immune-Checkpoint Inhibitor Diabetes Mellitus: An Integrative Review
Immune checkpoint inhibitor diabetes mellitus (ICI-DM) is an emerging phenomenon in the adult oncology population, with an increased incidence reflecting the increased use of immunotherapy; however, risk factors for ICI-DM have not been fully identified. The aim of this integrated literature review...
Saved in:
| Main Authors: | Vivian Crowder, Veronica Brady |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-07-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/15/7/1063 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rapid Recovery From Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State in Two Patients With Severe Hyperglycemia
by: Yuexin Yang, et al.
Published: (2025-03-01) -
Cemiplimab and diabetic ketoacidosis: a case report of a rare endocrinopathy associated with immune checkpoint inhibitors
by: Anna Arecco, et al.
Published: (2025-03-01) -
Does Pre-Existing Chronic Obstructive Pulmonary Disease Increase the Risk of Checkpoint Inhibitor Pneumonitis in Advanced/Metastatic Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors?
by: David Spillane, et al.
Published: (2025-04-01) -
Immune checkpoint inhibitor-associated diabetes mellitus: the case series report
by: Yuhong Ma, et al.
Published: (2025-07-01) -
Janus kinase and signal transducer and activator of transcription inhibitors in type 1 diabetes and immune checkpoint–related diabetes: current status and future perspectives
by: Bowei Su, et al.
Published: (2025-06-01)